A314930 Stock Overview
Biodyne Co., Ltd. develops and manufacturers medical devices, reagents, and consumables in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Biodyne Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩8,630.00 |
| 52 Week High | ₩16,210.00 |
| 52 Week Low | ₩5,910.00 |
| Beta | 1.45 |
| 1 Month Change | -14.13% |
| 3 Month Change | -22.67% |
| 1 Year Change | 40.55% |
| 3 Year Change | -36.17% |
| 5 Year Change | n/a |
| Change since IPO | 1.29% |
Recent News & Updates
Recent updates
Shareholder Returns
| A314930 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -1.6% | 3.5% | -2.4% |
| 1Y | 40.6% | 22.2% | 1.9% |
Return vs Industry: A314930 exceeded the KR Medical Equipment industry which returned 22.2% over the past year.
Return vs Market: A314930 exceeded the KR Market which returned 1.9% over the past year.
Price Volatility
| A314930 volatility | |
|---|---|
| A314930 Average Weekly Movement | 11.4% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A314930's share price has been volatile over the past 3 months.
Volatility Over Time: A314930's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | n/a | Wayne Im | www.biodyne.asia |
Biodyne Co., Ltd. develops and manufacturers medical devices, reagents, and consumables in South Korea. It offers PATHPLORER LBC system instruments and reagents, as well as consumable kits. The company exports its products to Russia, Germany, Italy, Spain, Portugal, Poland, China, Taiwan, and Thailand.
Biodyne Co., Ltd. Fundamentals Summary
| A314930 fundamental statistics | |
|---|---|
| Market cap | ₩256.86b |
| Earnings (TTM) | -₩991.76m |
| Revenue (TTM) | ₩4.09b |
62.8x
P/S Ratio-259.0x
P/E RatioIs A314930 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A314930 income statement (TTM) | |
|---|---|
| Revenue | ₩4.09b |
| Cost of Revenue | ₩3.40b |
| Gross Profit | ₩684.27m |
| Other Expenses | ₩1.68b |
| Earnings | -₩991.76m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -33.32 |
| Gross Margin | 16.74% |
| Net Profit Margin | -24.26% |
| Debt/Equity Ratio | 0% |
How did A314930 perform over the long term?
See historical performance and comparison